EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells

Mark F Bird, Christopher P Hebbes, Anushuya Tamang, Jonathon Mark Willets iD, Jonathan P Thompson iD, Remo Guerrini iD, Girolamo Calo iD, David G Lambert iD

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2023. Verfasst von Mark F Bird und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Receptors, Opioid, Sepsis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose In animal models of sepsis, increased activation of the Nociceptin/Orphanin FQ (N/OFQ) receptor NOP is associated with mortality and NOP antagonists improved survival. We have explored the role of the N/OFQ‐NOP system in freshly isolated volunteer human B‐ and T‐cells incubated with lipopolysaccharide (LPS) and peptidoglycan G (PepG) as a model of in vitro sepsis. Experimental Approach B‐ and T‐cell NOP expression was measured using the NOP fluorescent probe N/OFQ ATTO594 , N/OFQ content was measured using immunofluorescence, N/OFQ release was tracked using a CHO hNOPGαiq5 biosensor assay and NOP function was measured using transwell migration and cytokine/chemokine release using a 25‐plex assay format. Cells were challenged with LPS/PepG. Key Results CD19‐positive B‐cells bound N/OFQ ATTO594 ; they also contain N/OFQ. Stimulation with CXCL13/IL‐4 increased N/OFQ release. N/OFQ trended to reduced migration to CXCL13/IL‐4. Surface NOP expression was unaffected by LPS/PepG, but this treatment increased GM‐CSF release in an N/OFQ sensitive manner. CD3‐positive T‐cells did not bind N/OFQ ATTO594 ; they did contain N/OFQ. Stimulation with CXCL12/IL‐6 increased N/OFQ release. When incubated with LPS/PepG, NOP surface expression was induced leading to N/OFQ ATTO594 binding. In LPS/PepG‐treated cells, N/OFQ reduced migration to CXCL12/IL‐6. LPS/PepG increased GM‐CSF release in an N/OFQ sensitive manner. Conclusions and Implications We suggest both a constitutive and sepsis‐inducible N/OFQ‐NOP receptor autocrine regulation of B‐ and T‐cell function, respectively. These NOP receptors variably inhibit migration and reduce GM‐CSF release. These data provide mechanistic insights to the detrimental role for increased N/OFQ signalling in sepsis and suggest a potential role for NOP antagonists as treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, OpioidSepsisAnimalsHumansNociceptin ReceptorGranulocyte-Macrophage Colony-Stimulating FactorLipopolysaccharidesInterleukin-4Interleukin-6Opioid PeptidesNociceptin

Stichwörter der Autor:innen

B-cellsNOP receptorNociceptin/Orphanin FQT-cellsbiosensorconfocal microscopysepsis

Substanzen

Receptors, OpioidNociceptin ReceptorGranulocyte-Macrophage Colony-Stimulating FactorLipopolysaccharidesInterleukin-4Interleukin-6Opioid PeptidesNociceptin

Autor:innen und Institutionen

  • Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester, UK.
  • Cellomatics Biosciences Ltd, Nottingham, UK.
  • Molecular and Cell Biology, University of Leicester, Leicester, UK.
  • Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy.

ORCID-Profile: Jonathon Mark Willets, Jonathan P Thompson, Remo Guerrini, Girolamo Calo, David G Lambert

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Bird, M. F., Hebbes, C. P., Tamang, A., Willets, J. M., Thompson, J. P., Guerrini, R., Calo, G., & Lambert, D. G. (2023). In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells. British Journal of Pharmacology. https://doi.org/10.1111/bph.16088

Vancouver

Bird MF, Hebbes CP, Tamang A, Willets JM, Thompson JP, Guerrini R, et al. In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells. British Journal of Pharmacology. 2023. doi:10.1111/bph.16088

BibTeX
@article{Bird2023,
  author = {Bird, Mark F and Hebbes, Christopher P and Tamang, Anushuya and Willets, Jonathon Mark and Thompson, Jonathan P and Guerrini, Remo and Calo, Girolamo and Lambert, David G},
  title = {In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16088}
}
Kostenlos starten →